Fmoc-L-valine|02470|68858-20-8

Fmoc-L-valine

$35.90

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI02470_25_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Fmoc-L-valine
Brand Name
Chem Impex
Product Number
02470
CAS
68858-20-8
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
688217
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid
InChI Key
UGNIYGNGCNXHTR-SFHVURJKSA-N
SMILES
CC(C)C@@H(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Application

Fmoc-L-valine is widely utilized in research focused on

Peptide Synthesis: This compound serves as a protecting group in solid-phase peptide synthesis, allowing for the selective modification of amino acids without affecting other functional groups.

Drug Development: Researchers use Fmoc-L-valine in the design of peptide-based therapeutics, enhancing the stability and bioavailability of drug candidates.

Biotechnology: In the production of recombinant proteins, this chemical aids in the incorporation of specific amino acids, improving the yield and functionality of the proteins.

Analytical Chemistry: Fmoc-L-valine is employed in chromatography techniques for the separation and analysis of amino acids and peptides, providing high-resolution results.

Education and Training: This compound is commonly used in academic laboratories to teach students about peptide synthesis and the importance of protecting groups in organic chemistry.

References Data Source From Pubchem

157Gd-DHK: enhancing targeted gadolinium neutron capture for pancreatic adenocarcinoma
Publication Name: Journal of Cancer Research and Clinical Oncology
Publication Date: 2025-12-04
DOI: 10.1007/s00432-025-06368-7

Novel octapeptide containing the RGD sequence as a potential anti-SARS-CoV-2 agent: design, synthesis, and theoretical studies
Publication Name: Amino Acids
Publication Date: 2025-11-20
DOI: 10.1007/s00726-025-03480-3

Baicalin nano-micelles for dry eye disease: LC–MS/MS method validation, pharmacokinetics and pharmacodynamics in preclinical models
Publication Name: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Publication Date: 2025-10-09
DOI: 10.1007/s44446-025-00037-z

A bioinformatics approach to design minimal biomimetic metal-binding peptides
Publication Name: Communications Chemistry
Publication Date: 2025-10-06
DOI: 10.1038/s42004-025-01702-z

Protolytic properties and biological activity of spinorphin and its butyric acid derivatives in aqueous solution
Publication Name: Amino Acids
Publication Date: 2025-09-18
DOI: 10.1007/s00726-025-03481-2